Latest Tax Refunds News

Page 13 of 14
Nimy Resources advances its Mons Project with significant high-grade copper and gallium mineralisation confirmed at Masson and Block 3 East prospects, supported by a successful capital raise and a CSIRO research grant.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Imugene Limited reports durable patient responses in multiple cancer immunotherapy trials and strengthens its financial position with a $46 million convertible note deal and a substantial R&D tax refund.
Ada Torres
Ada Torres
31 Jan 2025
Elixir Energy wraps up Daydream-2 well operations and prepares for next appraisal in a strengthening gas market, while progressing farmout talks for Australian and Mongolian assets.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.
Ada Torres
Ada Torres
31 Jan 2025
Neurotech International has secured a $2.44 million R&D tax incentive refund, strengthening its cash position as it advances clinical trials for paediatric neurological disorders and prepares for regulatory submissions in FY2025.
Ada Torres
Ada Torres
31 Jan 2025
Activeport Group Ltd reported steady revenue of $2.5 million in Q2 FY25, maintaining a stable cost structure post-restructure and positioning itself for growth through new projects and a significant GPU orchestration licensing deal.
Victor Sage
Victor Sage
30 Jan 2025
Hastings Technology Metals has secured a strategic non-binding MOU with Saudi Arabia’s Ministry of Investment to explore a rare earths processing facility, while reporting encouraging developments at its Yangibana Project and maintaining solid financial footing.
Maxwell Dee
Maxwell Dee
30 Jan 2025
EcoGraf Limited advances its vertically integrated battery anode materials business with a significant UFK loan mandate and progress across upstream, midstream, and downstream operations.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.
Ada Torres
Ada Torres
30 Jan 2025
Agrimin Limited has achieved a major milestone with Western Australian state environmental approval for its Mackay Potash Project, alongside government-backed financial support and strategic progress toward project execution.
Victor Sage
Victor Sage
29 Jan 2025
Swift Networks reports steady cash flow and contract wins in mining and aged care, while unveiling a new feature to capitalize on upcoming aged care legislation.
Sophie Babbage
Sophie Babbage
28 Jan 2025
Galilee Energy reports a $1.9 million R&D tax refund and terminates its merger with Vintage Energy, while maintaining steady progress at its Glenaras Gas Project and a robust cash position of $4.38 million.
Maxwell Dee
Maxwell Dee
24 Jan 2025